INSYS

INSYQ OTCMKTS
0.3060
+0.0161
+5.55%
交易中 13:45 06/24 EDT
开盘
0.2801
昨收
0.2899
最高
0.3150
最低
0.2800
成交量
73.33万
成交均量(3M)
379.64万
52周最高
11.65
52周最低
0.1420
换手率
0.98%
市值
2,281.82万
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供INSYS INSYQ股票价格,INSYS股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Insys Therapeutics, Inc. is a commercial-stage specialty pharmaceutical company. The Company develops and commercializes supportive care products. The Company's product Subsys, is a sublingual fentanyl spray for breakthrough cancer pain (BTCP) in opioid-tolerant patients and a single-use product that delivers fentanyl, an opioid analgesic, for transmucosal absorption underneath the tongue. The Company markets Subsys through its field sales force focused on supportive care physicians in the United States. Subsys delivers a liquid fentanyl formulation in approximately 100, 200, 400, 600, 800, 1,200 and 1,600 micrograms (mcg) dosages. The Company's lead dronabinol product candidate is Syndros, which is under review for approval at the Food and Drug Administration. In addition, the Company is evaluating sublingual spray, inhaled and intravenous formulations of dronabinol in preclinical studies.
展开 >

最近浏览

名称
价格
涨跌幅